A randomised, double-blind, placebo-controlled trial of erythropoietin alfa versus placebo in machnically ventilated critically ill patients following traumatic injury. (ACTRN12619001632189)
EPO_TRAUMA
This trial is Currently recruiting
Registration number ACTRN12619001632189
Program & service
This trial is being run with the Intensive Care Services service, and as part of the Intensive Care program.
Trial phase
Phase 3
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Professor Andrew Udy, Dr Dashiell Gantner
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTRIf you would like further details or have any questions about this clinical trial, we encourage you to get in touch with us and a member of our team will be happy to provide you with more information.